Evidence map›Paper›PMID 23851719›Full record

ArticleScientific reports2013

Spt6 prevents transcription-coupled loss of posttranslationally modified histone H3.

Hiroaki Kato, Kosuke Okazaki, Tetsushi Iida, Jun-Ichi Nakayama, Yota Murakami, Takeshi Urano

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Hiroaki KatoDepartment of Biochemistry, Shimane University School of Medicine, Izumo, Japan. hkato@med.shimane-u.ac.jp
Kosuke Okazaki
Tetsushi Iida
Jun-Ichi Nakayama
Yota Murakami
Takeshi Urano
Shimane University · JPHokkaido University · JPJapan Science and Technology Agency · JPRIKEN Center for Biosystems Dynamics Research · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tail of histone H3 is an ideal medium for storing epigenetic information because displacement of histone H3 is heavily restricted during transcription. To maintain the locus-specific modifications of histone H3, histone molecules should be retained locally at the original position through multiple rounds of transcription. Here, we found that fission yeast Spt6, a highly conserved RNA polymerase II-interacting histone H3-H4 chaperone, is essential for the maintenance of Lys-4 and Lys-9 methylation of histone H3 in euchromatin and heterochromatin, respectively. In euchromatin, loss of Lys-4 methylated histone H3 and deposition of newly synthesized Lys-56 acetylated histone H3 induced by Spt6 inactivation were coupled with transcription. While in heterochromatin, Spt6 prevents histone turnover and cryptic transcription in parallel with Clr3 histone deacetylase. We propose that Spt6 retains posttranslationally modified histone H3 during transcription to maintain epigenome integrity.

Indexed as

Protein Processing, Post-TranslationalTranscription, GeneticAcetylationCell Cycle ProteinsGene OrderHeterochromatinHistone ChaperonesHistone DeacetylasesHistonesLysineMethylationModels, BiologicalMolecular Sequence DataMutationNucleosomesSchizosaccharomycesCell Cycle ProteinsClr3 protein, S pombeHeterochromatinHistone ChaperonesHistone DeacetylasesHistonesLysineNucleosomesSchizosaccharomyces pombe ProteinsSpt6 protein, S pombe

Identifiers

PMID23851719
PMCPMC3711048
OpenAlexW1984085338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.